Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?

समान संसाधन

• How I treat metastatic triple-negative breast cancer
  द्वारा: Caparica, Rafael, और अन्य
  प्रकाशित: (2019)
• ESMO 2018 presidential symposium—IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer
  द्वारा: Schmid, Peter
  प्रकाशित: (2018)
• Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
  द्वारा: Iwata, Hiroji, और अन्य
  प्रकाशित: (2019)
• Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
  द्वारा: Iwata, Hiroji, और अन्य
  प्रकाशित: (2020)
• LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
  द्वारा: Emens, L.A., और अन्य
  प्रकाशित: (2020)